ticlopidine has been researched along with Polycythemia Vera in 7 studies
Ticlopidine: An effective inhibitor of platelet aggregation commonly used in the placement of STENTS in CORONARY ARTERIES.
ticlopidine : A thienopyridine that is 4,5,6,7-tetrahydrothieno[3,2-c]pyridine in which the hydrogen attached to the nitrogen is replaced by an o-chlorobenzyl group.
Polycythemia Vera: A myeloproliferative disorder of unknown etiology, characterized by abnormal proliferation of all hematopoietic bone marrow elements and an absolute increase in red cell mass and total blood volume, associated frequently with splenomegaly, leukocytosis, and thrombocythemia. Hematopoiesis is also reactive in extramedullary sites (liver and spleen). In time myelofibrosis occurs.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (28.57) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pedersen, OH | 1 |
| Larsen, ML | 1 |
| Kristensen, SD | 1 |
| Hvas, AM | 1 |
| Grove, EL | 1 |
| Robier, C | 1 |
| Neubauer, M | 1 |
| Sternad, H | 1 |
| Quehenberger, F | 1 |
| Rainer, F | 1 |
| Neumeister, P | 1 |
| Friess, D | 1 |
| Lämmle, B | 1 |
| Alberio, L | 1 |
| Landolfi, R | 1 |
| Di Gennaro, L | 1 |
| Triller, R | 1 |
| Renard, T | 1 |
| de Lacharrière, O | 1 |
| Léonard, F | 1 |
| Caulet, T | 1 |
| Kalis, B | 1 |
| Finelli, C | 1 |
| Palareti, G | 1 |
| Poggi, M | 1 |
| Torricelli, P | 1 |
| Vianelli, N | 1 |
| Fiacchini, M | 1 |
| Zuffa, E | 1 |
| Ricci, P | 1 |
| Gugliotta, L | 1 |
| Coccheri, S | 1 |
| Indrák, K | 1 |
| Kapustová, M | 1 |
| Hrcková, Y | 1 |
| Kubis, M | 1 |
| Scudla, V | 1 |
| Jezdinský, J | 1 |
1 trial available for ticlopidine and Polycythemia Vera
| Article | Year |
|---|---|
Ticlopidine lowers plasma fibrinogen in patients with polycythaemia rubra vera and additional thrombotic risk factors. A double-blind controlled study.
Topics: Aged; Aged, 80 and over; Blood Viscosity; Double-Blind Method; Fibrinogen; Humans; Male; Middle Aged | 1991 |
6 other studies available for ticlopidine and Polycythemia Vera
| Article | Year |
|---|---|
Recurrent Cardiovascular Events Despite Antiplatelet Therapy in a Patient with Polycythemia Vera and Accelerated Platelet Turnover.
Topics: Adenosine; Brain Infarction; Clopidogrel; Drug Therapy, Combination; Humans; Male; Middle Aged; Myoc | 2017 |
Evaluation of platelet function and pharmacological platelet inhibition in patients with myeloproliferative disorders using multiple electrode aggregometry.
Topics: Adenosine Diphosphate; Adult; Aged; Arachidonic Acid; Aspirin; Austria; Case-Control Studies; Clopid | 2010 |
Qualitative platelet defect and thrombohaemorrhagic complications in a patient with polycythaemia vera. Case 10.
Topics: Aged; Aspirin; Blood Platelet Disorders; Clopidogrel; Hemorrhage; Humans; Male; Platelet Aggregation | 2003 |
Prevention of thrombosis in polycythemia vera and essential thrombocythemia.
Topics: Arterial Occlusive Diseases; Aspirin; Clopidogrel; Dipyridamole; Drug Therapy, Combination; Humans; | 2008 |
[Darier's erythema annulare centrifugum and primary Vaquez polycythemia].
Topics: Aged; Erythema; Follow-Up Studies; Humans; Male; Paraneoplastic Syndromes; Phosphorus Radioisotopes; | 1984 |
Comparison of the effects of acylpyrin, curantyl and ticlid on some platelet functions in patients with polycythemia vera.
Topics: Adult; Aged; Aspirin; Blood Platelets; Dipyridamole; Female; Humans; Male; Middle Aged; Platelet Agg | 1985 |